Medicamen Biotech Ltd Sustainability Reports
Medicamen Biotech Limited manufactures and markets generic pharmaceutical formulations across various therapeutic areas, including oncology, cardiovascular, central nervous system, and diabetes. The company operates multiple manufacturing facilities in India and exports products globally to regulated and rest-of-the-world markets.
Sector: Manufacturing
Country: India
Exchange: Bombay Stock Exchange
LEI: 894500T0ULD27B7W4Y03
FIGI: BBG001S8LX58
12 reports from 2003 to 2026
- Medicamen Biotech Ltd 2026 Annexure-D to Board's Report Business Responsibility and Sustainability Report
- Medicamen Biotech Ltd 2025 Business Responsibility and Sustainability Report
- Medicamen Biotech Ltd 2024 Annual Report
- Medicamen Biotech Ltd 2024 Business Responsibility and Sustainability Report
- Medicamen Biotech Ltd 2023 Annual Report